Has Gopi Dandamudi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $82,012 in general payments to Gopi Dandamudi, MD across 177 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gopi Dandamudi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gopi Dandamudi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gopi Dandamudi, MD

Clinical Cardiac Electrophysiology · Clemson, SCNPI 1356500946

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $53,596 of the $82,012 with a category attached, or 65.4%. Medtronic accounts for 79.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $32,224 and has fallen 83.4% since, to $5,364 in 2025.

$82,012in general payments, 2019–2025

Across 177 payments — averaging $463.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$65K
Abbott$10K
Biotronik Inc.$6K
Atricure, Inc.$278
Boston Scientific$220
Alnylam Pharmaceuticals Inc.$20
plus $27 from 2 others

$16,450in research payments, 2019–2025

Across 14 payments — averaging $1174.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$16K
Medtronic$700

What the payments were for

Consulting fees$6,5138%
Speaking & faculty fees$53,59665%
Travel & lodging$15,20719%
Food & beverage$6,6978%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	134	$65,340
Abbott	29	$10,027
Biotronik Inc.	6	$6,101
Atricure, Inc.	2	$278
Boston Scientific	2	$220
Alnylam Pharmaceuticals Inc.	1	$20
E.r. Squibb & Sons, L.L.C.	1	$16
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SelectSecure$14,300
Agilis NxT EP Introducer$7,146
AVEIR$1,673
Micra$1,304
CARDIOBLATE CRYOFLEX$743
DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$382
ARCTIC FRONT ADVANCE$367
AZURE XT DR MRI SURESCAN$290
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$214
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$188
ASSURITY$134
Arctic Front$132
Confirm Rx$128
Watchman$123
Solia$118
Rivacor$118
Edora$118
BioMonitor$118
Acticor$118
EnSite Precision Cardiac Mapping System$114

How this compares

$82,012 in reported general payments places this provider in the 70th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.

See all clinical cardiac electrophysiology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$68,144

Medicare patients

330

Services billed

898

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	14	$13,764
EliquisApixaban	15	$13,304
Flecainide Acetate	48	$1,563
Metoprolol Succinate	21	$269
Digoxin	14	$121
Carvedilol	15	$66

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Clemson

Chad WardClemson$126K
Jeffrey WinterfieldCharleston$498K
Frank CuocoCharleston$306K
Anne KromanCharleston$279K
Andrew BrenyoRock Hill$241K
Joseph ManfrediGreenville$213K
Michael GoldCharleston$204K
Sultan SiddiqueColumbia$182K
Peter NetzlerGreenville$146K
Yuxuan MaoLittle River$126K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →